FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission

Browse by...

Deposit

Highlights

More informations

Title		FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission
Authors		Beauverd, Yan Tsopra, Olga Roosnek, Eddy Emile Simon, AUDREY Grandjean, Anne-Pascale Tirefort, Yordanka Dantin, Carole Alice Masouridi-Levrat, Stavroula Chalandon, Yves show all authors [1 - 9]
Published in		Hematological Oncology. 2017, vol. 35, no. 3, p. 392-394
Identifiers		DOI: 10.1002/hon.2272 PMID: 26563907
Full text		Article (Published version) (100 Kb) - Limited access to UNIGE
Structures		Faculté de médecine
Research group		Groupe Roosnek Eddy (hémato-oncologie) (19)
Citation (ISO format)		BEAUVERD, Yan et al. FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission. In: Hematological Oncology, 2017, vol. 35, n° 3, p. 392-394. https://archive-ouverte.unige.ch/unige:84044